Furthermore, mutant p53 induces miR-34 dysregulation, increasing the expression of immune checkpoint molecules such as PD-L1, further reinforcing the immunosuppressive tumor microenvironment [69,70]. The gene discussed is TP53; the disease is neoplasm.